Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Patrangsit Healthcare Group PCLBKK:PHG +1.98%43 EBITDA Margin % is 13.93% as of Mar. 2026, which is 29% below its 10-year median of 19.68. GuruFocus rates BKK:PHG with a GF Score™ of 43/100 and a GF Value™ of ฿15.90 (Significantly Undervalued). Among 665 Healthcare Providers & Services companies, Patrangsit Healthcare Group PCL ranks better than 69.92% on this metric.
Patrangsit Healthcare Group PCL (BKK:PHG) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Patrangsit Healthcare Group PCL EBITDA Margin % Related Terms
Patrangsit Healthcare Group PCL EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Patrangsit Healthcare Group PCL EBITDA Margin % Chart
BKK:PHG vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Patrangsit Healthcare Group PCL's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Patrangsit Healthcare Group PCL EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Patrangsit Healthcare Group PCL's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Patrangsit Healthcare Group PCL's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Patrangsit Healthcare Group PCL (BKK:PHG) has a EBITDA Margin % of 13.93% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Patrangsit Healthcare Group PCL and its competitors. This is 29% below median its historical median of 19.68. Over the past decade, Patrangsit Healthcare Group PCL's EBITDA Margin % has ranged from 18.09 to 24.48. According to the industry distribution chart, Patrangsit Healthcare Group PCL ranks #200 out of 665 companies in the Healthcare Providers & Services industry, placing it in the top 30.1%.
Is Patrangsit Healthcare Group PCL's EBITDA Margin % too high?
Patrangsit Healthcare Group PCL's current EBITDA Margin % of 13.93% is 29% below median its 10-year median of 19.68. Over the past 10 years, this metric has ranged from a low of 18.09 to a high of 24.48. The Healthcare Providers & Services industry median EBITDA Margin % is 10.24. Patrangsit Healthcare Group PCL's value of 13.93% is 36% above this industry median. Based on the distribution chart, Patrangsit Healthcare Group PCL ranks #200 out of 665 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Patrangsit Healthcare Group PCL has a GF Score™ of 43/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Patrangsit Healthcare Group PCL's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Patrangsit Healthcare Group PCL ranks #200 out of 665 companies for EBITDA Margin %. This puts Patrangsit Healthcare Group PCL in the upper half of its industry. The industry median EBITDA Margin % is 10.24. Patrangsit Healthcare Group PCL's value of 13.93% is 36% above this benchmark. Historically, Patrangsit Healthcare Group PCL's own EBITDA Margin % has ranged from 18.09 to 24.48 over the past decade. While the company's 10-year median is 19.68 vs. the industry median of 10.24, Patrangsit Healthcare Group PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.24, based on 665 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Patrangsit Healthcare Group PCL's current EBITDA Margin % of 13.93% is 36% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Patrangsit Healthcare Group PCL and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Patrangsit Healthcare Group PCL's current EBITDA Margin % is 13.93%, which is 29% below median its own 10-year median of 19.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Patrangsit Healthcare Group PCL stock overvalued right now?
Based on GuruFocus' analysis, Patrangsit Healthcare Group PCL (BKK:PHG) is currently considered Significantly Undervalued. The stock's GF Value™ is ฿15.90, compared to a current price of ฿10.30 — trading 35.2% below its estimated fair value. The current EBITDA Margin % is 13.93%, which is 29% below median its 10-year median of 19.68 and 36% above the Healthcare Providers & Services industry median of 10.24. Patrangsit Healthcare Group PCL's overall GF Score™ is 43/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Patrangsit Healthcare Group PCL (BKK:PHG), the current EBITDA Margin % is 13.93% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Patrangsit Healthcare Group PCL (BKK:PHG) Overvalued in 2026?
Based on GuruFocus' analysis, Patrangsit Healthcare Group PCL stock appears to be undervalued.
The current stock price of ฿10.30 is trading 35.2% below its estimated GF Value™ of ฿15.90.
GuruFocus considers Patrangsit Healthcare Group PCL to be Significantly Undervalued.
Key valuation signals for BKK:PHG:
EBITDA Margin %: 13.93% (29% below median its 10-year median of 19.68)
GF Value™: ฿15.90 vs. price of ฿10.30 (35.2% below fair value)
Industry Position: 36% above the Healthcare Providers & Services median (#200 of 665)
No single metric tells the full story. See the BKK:PHG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Patrangsit Healthcare Group PCL Business Description
Patrangsit Healthcare Group PCL engages in the operations of the hospital business. The company's services include medical services, wardroom, health insurance customer services, corporate customer services and international services. It operates in one main reportable operating segment, which is hospital business and operates in one geographical area, which is Thailand.
43GF Score
Get the complete analysis for BKK:PHG
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:PHG has been successfully added to your 
